G M Baerlocher
Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV
Miranda M, Neben K, Heinl C, Mahlberg R, Plöger C, Flasshove M, Rendenbach B, Hofmann W, Müller M, Pfirrmann M, Hochhaus A, Hasford J, Hehlmann R, Prümmer O, Fauser A, Verbeek W, Lauseker M, Kraus M, Proetel U, Hanfstein B, Fabarius A, Baerlocher G, Heim D, Hossfeld D, Kolb H, Krause S, Nerl C, Brümmendorf T, Saußele S. Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV. Leukemia 2016; 30:1255-62.
Feb 9, 2016Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV
Feb 9, 2016Leukemia 2016; 30:1255-62
Miranda M B, Neben K, Heinl Christina, Mahlberg R, Plöger C, Flasshove M, Rendenbach B, Hofmann W-K, Müller M C, Pfirrmann M, Hochhaus A, Hasford J, Hehlmann R, Prümmer O, Fauser A A, Verbeek W, Lauseker M, Kraus M-P, Proetel U, Hanfstein B, Fabarius A, Baerlocher G M, Heim D, Hossfeld D K, Kolb H-J, Krause S W, Nerl C, Brümmendorf T H, Saußele S
Ifosfamide-induced stomatocytosis and mesna-induced echinocytosis: influence on biorheological properties of blood
Reinhart W, Baerlocher G, Cerny T, Owen G, Meiselman H, Beer J. Ifosfamide-induced stomatocytosis and mesna-induced echinocytosis: influence on biorheological properties of blood. European journal of haematology 1999; 62:223-30.
Apr 1, 1999Ifosfamide-induced stomatocytosis and mesna-induced echinocytosis: influence on biorheological properties of blood
Apr 1, 1999European journal of haematology 1999; 62:223-30
Reinhart W H, Baerlocher G M, Cerny Thomas, Owen G R, Meiselman H J, Beer J H